FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19504511000001109: Asenapine maleate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Oct 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
66064701000001115 Asenapine maleate (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
66064801000001112 Asenapine maleate en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Asenapine maleate Is a Asenapine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Asenapine 10mg sublingual tablets sugar free Has specific active ingredient True Asenapine maleate Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free Has specific active ingredient True Asenapine maleate Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) Has specific active ingredient True Asenapine maleate Inferred relationship Existential restriction modifier
Sycrest 5mg sublingual tablets (Organon Pharma (UK) Ltd) Has specific active ingredient True Asenapine maleate Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free 60 tablet Has specific active ingredient True Asenapine maleate Inferred relationship Existential restriction modifier
Asenapine 10mg sublingual tablets sugar free 60 tablet Has specific active ingredient True Asenapine maleate Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has specific active ingredient True Asenapine maleate Inferred relationship Existential restriction modifier
Sycrest 5mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has specific active ingredient True Asenapine maleate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start